Clinical Trials | May 14, 2026
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
We are building an AI-native operating system for pharma sales and distribution
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
Subscribe To Our Newsletter & Stay Updated
